TY - JOUR
T1 - Deciphering the genetics of hereditary non-syndromic colorectal cancer
AU - CORGI Consortium
AU - Papaemmanuil, Eli
AU - Carvajal-Carmona, Luis
AU - Sellick, Gabrielle S
AU - Kemp, Zoe
AU - Webb, Emily
AU - Spain, Sarah
AU - Sullivan, Kate
AU - Barclay, Ella
AU - Lubbe, Steven
AU - Jaeger, Emma
AU - Vijayakrishnan, Jayaram
AU - Broderick, Peter
AU - Gorman, Maggie
AU - Martin, Lynn
AU - Lucassen, Anneke
AU - Bishop, D Timothy
AU - Evans, D Gareth
AU - Maher, Eamonn R
AU - Steinke, Verena
AU - Rahner, Nils
AU - Schackert, Hans K
AU - Goecke, Timm O
AU - Holinski-Feder, Elke
AU - Propping, Peter
AU - Van Wezel, Tom
AU - Wijnen, Juul
AU - Cazier, Jean-Baptiste
AU - Thomas, Huw
AU - Houlston, Richard S
AU - Tomlinson, Ian
PY - 2008/12
Y1 - 2008/12
N2 - Previously we have localized to chromosome 3q21-q24, a predisposition locus for colorectal cancer (CRC), through a genome-wide linkage screen (GWLS) of 69 families without familial adenomatous polyposis or hereditary non-polyposis CRC. To further investigate Mendelian susceptibility to CRC, we extended our screen to include a further GWLS of an additional 34 CRC families. We also searched for a disease gene at 3q21-q24 by linkage disequilibrium mapping in 620 familial CRC cases and 960 controls by genotyping 1676 tagging SNPs and sequencing 30 candidate genes from the region. Linkage analysis was conducted using the Affymetrix 10K SNP array. Data from both GWLSs were pooled and multipoint linkage statistics computed. The maximum NPL score (3.01; P=0.0013) across all families was at 3q22, maximal evidence for linkage coming from families segregating rectal CRC. The same genomic position also yielded the highest multipoint heterogeneity LOD (HLOD) score under a dominant model (HLOD=2.79; P=0.00034), with an estimated 43% of families linked. In the case-control analysis, the strongest association was obtained at rs698675 (P=0.0029), but this was not significant after adjusting for multiple testing. Analysis of candidate gene mapping to the region of maximal linkage on 3q22 failed to identify a causal mutation. There was no evidence for linkage to the previously reported 9q CRC locus (NPL=0.95, P=0.23; HLOD(dominant)=0.40, HLOD(recessive)=0.20). Our findings are consistent with the hypothesis that variation at 3q22 contributes to the risk of CRC, but this is unlikely to be mediated through a restricted set of alleles.
AB - Previously we have localized to chromosome 3q21-q24, a predisposition locus for colorectal cancer (CRC), through a genome-wide linkage screen (GWLS) of 69 families without familial adenomatous polyposis or hereditary non-polyposis CRC. To further investigate Mendelian susceptibility to CRC, we extended our screen to include a further GWLS of an additional 34 CRC families. We also searched for a disease gene at 3q21-q24 by linkage disequilibrium mapping in 620 familial CRC cases and 960 controls by genotyping 1676 tagging SNPs and sequencing 30 candidate genes from the region. Linkage analysis was conducted using the Affymetrix 10K SNP array. Data from both GWLSs were pooled and multipoint linkage statistics computed. The maximum NPL score (3.01; P=0.0013) across all families was at 3q22, maximal evidence for linkage coming from families segregating rectal CRC. The same genomic position also yielded the highest multipoint heterogeneity LOD (HLOD) score under a dominant model (HLOD=2.79; P=0.00034), with an estimated 43% of families linked. In the case-control analysis, the strongest association was obtained at rs698675 (P=0.0029), but this was not significant after adjusting for multiple testing. Analysis of candidate gene mapping to the region of maximal linkage on 3q22 failed to identify a causal mutation. There was no evidence for linkage to the previously reported 9q CRC locus (NPL=0.95, P=0.23; HLOD(dominant)=0.40, HLOD(recessive)=0.20). Our findings are consistent with the hypothesis that variation at 3q22 contributes to the risk of CRC, but this is unlikely to be mediated through a restricted set of alleles.
KW - Adenoma/genetics
KW - Case-Control Studies
KW - Chromosome Mapping
KW - Chromosomes, Human, Pair 3
KW - Colorectal Neoplasms/genetics
KW - DNA Mutational Analysis
KW - Family
KW - Family Health
KW - Gene Dosage
KW - Genetic Linkage
KW - Genome-Wide Association Study
KW - Humans
KW - Lod Score
KW - Polymorphism, Single Nucleotide
U2 - 10.1038/ejhg.2008.129
DO - 10.1038/ejhg.2008.129
M3 - Article
C2 - 18628789
SN - 1018-4813
VL - 16
SP - 1477
EP - 1486
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 12
ER -